Chen Yih-Wen, Lang Mark L, Wade William F
Department of Microbiology and Immunology, Dartmouth Medical School, Lebanon, NH 03756, USA.
Traffic. 2004 Aug;5(8):577-94. doi: 10.1111/j.1600-0854.2004.00202.x.
Studies have demonstrated that receptor-mediated signaling, receptor/antigen complex trafficking, and major histocompatibility complex class II compartments (MIIC) are critically related to antigen presentation to CD4+ T cells. In this study, we investigated the role of protein kinase C (PKC) in FcalphaR/gammagamma (CD89, human IgA receptor)-mediated internalization of immune complexes and subsequent antigen presentation. The classical and novel PKC inhibitor, Calphostin C, inhibits FcalphaR-mediated antigen presentation and interaction of MIIC and cargo vesicle (receptor and antigen). PKC-alpha, PKC-delta, and PKC-epsilon were recruited to lipid rafts following FcalphaR crosslinking, the extent of which was determined by the phenotype of the gamma chain. Mutant gamma chain with an FcgammaRIIA ITAM (immunoreceptor tyrosine-based activation motif) insert was less able to recruit PKC and trigger antigen presentation. Both PKC isoform-specific peptide inhibitors and short interfering RNA (siRNA) showed that PKC-alpha and PKC-delta, but not PKC-epsilon, were required for association of cargo vesicle and MIIC and for FcalphaR-mediated and soluble antigen presentation. Inhibition of PKC (classical and novel) did not alter major histocompatibility class II biosynthesis, assembly, transport, or plasma membrane stability. PKC's role in facilitating interaction of cargo vesicle and MIIC is likely due to regulation of vesicle biology required for fusion of cargo vesicles to MIIC.
研究表明,受体介导的信号传导、受体/抗原复合物运输以及主要组织相容性复合体II类区室(MIIC)与向CD4+T细胞的抗原呈递密切相关。在本研究中,我们调查了蛋白激酶C(PKC)在FcalphaR/gammagamma(CD89,人IgA受体)介导的免疫复合物内化及随后的抗原呈递中的作用。经典和新型PKC抑制剂Calphostin C可抑制FcalphaR介导的抗原呈递以及MIIC与货物囊泡(受体和抗原)的相互作用。FcalphaR交联后,PKC-α、PKC-δ和PKC-ε被招募至脂筏,其程度由γ链的表型决定。带有FcgammaRIIA免疫受体酪氨酸-based激活基序(ITAM)插入的突变γ链招募PKC并触发抗原呈递的能力较弱。PKC亚型特异性肽抑制剂和短发夹RNA(siRNA)均表明,货物囊泡与MIIC的结合以及FcalphaR介导的和可溶性抗原呈递需要PKC-α和PKC-δ,而非PKC-ε。抑制PKC(经典和新型)不会改变主要组织相容性复合体II类的生物合成、组装、运输或质膜稳定性。PKC在促进货物囊泡与MIIC相互作用中的作用可能是由于对货物囊泡与MIIC融合所需的囊泡生物学的调节。